

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.11231783 |
| 2 | muscle filament sliding (GO:0030049) | 6.11231783 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95866824 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.94690855 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.37904344 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.25567142 |
| 7 | actin-mediated cell contraction (GO:0070252) | 5.22362917 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16455000 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.14356325 |
| 10 | vocalization behavior (GO:0071625) | 5.12126331 |
| 11 | layer formation in cerebral cortex (GO:0021819) | 5.09290030 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 5.02631122 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.99235321 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.89896798 |
| 15 | glutamate secretion (GO:0014047) | 4.81493959 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.78873991 |
| 17 | myofibril assembly (GO:0030239) | 4.77637015 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.66126309 |
| 19 | regulation of skeletal muscle contraction (GO:0014819) | 4.66064363 |
| 20 | regulation of cell communication by electrical coupling (GO:0010649) | 4.45780575 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.42857898 |
| 22 | protein localization to synapse (GO:0035418) | 4.41477967 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.40733430 |
| 24 | exploration behavior (GO:0035640) | 4.38515844 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.36580350 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.28875244 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 4.25517802 |
| 28 | skeletal muscle contraction (GO:0003009) | 4.23630064 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.20848529 |
| 30 | cardiac myofibril assembly (GO:0055003) | 4.18282116 |
| 31 | striated muscle contraction (GO:0006941) | 4.17727152 |
| 32 | presynaptic membrane organization (GO:0097090) | 4.14543588 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09302116 |
| 34 | proline transport (GO:0015824) | 4.09114769 |
| 35 | sarcomere organization (GO:0045214) | 4.08905095 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 4.07865578 |
| 37 | neurotransmitter secretion (GO:0007269) | 4.00967573 |
| 38 | presynaptic membrane assembly (GO:0097105) | 3.95731991 |
| 39 | actin filament-based movement (GO:0030048) | 3.92762954 |
| 40 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.91585611 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 3.91214064 |
| 42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.89944549 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.88835618 |
| 44 | dendrite morphogenesis (GO:0048813) | 3.82780657 |
| 45 | neuron recognition (GO:0008038) | 3.82182862 |
| 46 | response to inactivity (GO:0014854) | 3.80902615 |
| 47 | synaptic transmission, glutamatergic (GO:0035249) | 3.78817727 |
| 48 | regulation of actin filament-based movement (GO:1903115) | 3.78180708 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.77939756 |
| 50 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.76819391 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.73034816 |
| 52 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.71694714 |
| 53 | cardiac muscle contraction (GO:0060048) | 3.68808002 |
| 54 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.68210300 |
| 55 | cardiac muscle hypertrophy (GO:0003300) | 3.66529495 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.63108158 |
| 57 | neuron-neuron synaptic transmission (GO:0007270) | 3.60707256 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.57480555 |
| 59 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57068251 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 3.56695153 |
| 61 | axonal fasciculation (GO:0007413) | 3.55601255 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.53360599 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.52485561 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.50692067 |
| 65 | striated muscle hypertrophy (GO:0014897) | 3.49141188 |
| 66 | nucleobase catabolic process (GO:0046113) | 3.47186089 |
| 67 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.42122712 |
| 68 | plasma membrane repair (GO:0001778) | 3.41026263 |
| 69 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.40864326 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.36792834 |
| 71 | actomyosin structure organization (GO:0031032) | 3.36342578 |
| 72 | long-term memory (GO:0007616) | 3.35304948 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 3.32275205 |
| 74 | regulation of postsynaptic membrane potential (GO:0060078) | 3.31877485 |
| 75 | cell migration in hindbrain (GO:0021535) | 3.31547627 |
| 76 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.29760506 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25928901 |
| 78 | muscle contraction (GO:0006936) | 3.22988382 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21074513 |
| 80 | neuronal action potential propagation (GO:0019227) | 3.20566644 |
| 81 | innervation (GO:0060384) | 3.19390768 |
| 82 | neurotransmitter transport (GO:0006836) | 3.17790673 |
| 83 | response to muscle activity (GO:0014850) | 3.17342687 |
| 84 | synaptic vesicle endocytosis (GO:0048488) | 3.15947226 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.15424981 |
| 86 | sodium ion export (GO:0071436) | 3.12831529 |
| 87 | postsynaptic membrane organization (GO:0001941) | 3.11438974 |
| 88 | myotube cell development (GO:0014904) | 3.11400150 |
| 89 | vesicle transport along microtubule (GO:0047496) | 3.10934192 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 3.09331411 |
| 91 | neuromuscular synaptic transmission (GO:0007274) | 3.09057653 |
| 92 | skeletal muscle fiber development (GO:0048741) | 3.08864942 |
| 93 | regulation of synaptic plasticity (GO:0048167) | 3.07458974 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.06874146 |
| 95 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06603059 |
| 96 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06526082 |
| 97 | cell communication by electrical coupling (GO:0010644) | 3.05924705 |
| 98 | organelle transport along microtubule (GO:0072384) | 3.05432912 |
| 99 | regulation of sarcomere organization (GO:0060297) | 3.05327400 |
| 100 | establishment of nucleus localization (GO:0040023) | 3.03635195 |
| 101 | muscle hypertrophy (GO:0014896) | 3.01286426 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.01215251 |
| 103 | axon extension (GO:0048675) | 3.00115436 |
| 104 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.99655510 |
| 105 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.99655510 |
| 106 | auditory behavior (GO:0031223) | 2.99272759 |
| 107 | muscle fiber development (GO:0048747) | 2.98998334 |
| 108 | synapse assembly (GO:0007416) | 2.96963688 |
| 109 | prepulse inhibition (GO:0060134) | 2.96360665 |
| 110 | creatine metabolic process (GO:0006600) | 2.96334841 |
| 111 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.95296092 |
| 112 | clathrin coat assembly (GO:0048268) | 2.94963388 |
| 113 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.94555949 |
| 114 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.94456068 |
| 115 | transmission of nerve impulse (GO:0019226) | 2.94189897 |
| 116 | muscle system process (GO:0003012) | 2.93610779 |
| 117 | regulation of membrane repolarization (GO:0060306) | 2.93040056 |
| 118 | regulation of neurotransmitter levels (GO:0001505) | 2.92952390 |
| 119 | social behavior (GO:0035176) | 2.92786727 |
| 120 | intraspecies interaction between organisms (GO:0051703) | 2.92786727 |
| 121 | myotube differentiation (GO:0014902) | 2.92761009 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.92049799 |
| 123 | behavioral fear response (GO:0001662) | 2.91861289 |
| 124 | behavioral defense response (GO:0002209) | 2.91861289 |
| 125 | cardiac muscle cell development (GO:0055013) | 2.90647442 |
| 126 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.90496331 |
| 127 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89826216 |
| 128 | regulation of dendritic spine development (GO:0060998) | 2.89536156 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.88959009 |
| 130 | regulation of ARF protein signal transduction (GO:0032012) | 2.88644709 |
| 131 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.88638648 |
| 132 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.88574247 |
| 133 | response to auditory stimulus (GO:0010996) | 2.88413179 |
| 134 | long-term synaptic potentiation (GO:0060291) | 2.88041456 |
| 135 | regulation of striated muscle contraction (GO:0006942) | 2.87066565 |
| 136 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.85964638 |
| 137 | muscle hypertrophy in response to stress (GO:0003299) | 2.85964638 |
| 138 | cardiac muscle adaptation (GO:0014887) | 2.85964638 |
| 139 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.84373104 |
| 140 | synapse organization (GO:0050808) | 2.82113128 |
| 141 | dendritic spine organization (GO:0097061) | 2.81494973 |
| 142 | cerebellar granule cell differentiation (GO:0021707) | 2.79759995 |
| 143 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.78842769 |
| 144 | mitochondrion transport along microtubule (GO:0047497) | 2.78842769 |
| 145 | adult heart development (GO:0007512) | 2.78749115 |
| 146 | carnitine shuttle (GO:0006853) | 2.78006148 |
| 147 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.77845652 |
| 148 | regulation of vesicle fusion (GO:0031338) | 2.76550982 |
| 149 | membrane depolarization (GO:0051899) | 2.75741069 |
| 150 | striated muscle adaptation (GO:0014888) | 2.75608333 |
| 151 | positive regulation of cation channel activity (GO:2001259) | 2.75063644 |
| 152 | positive regulation of dendritic spine development (GO:0060999) | 2.74906968 |
| 153 | relaxation of cardiac muscle (GO:0055119) | 2.74360513 |
| 154 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.74338669 |
| 155 | glycogen catabolic process (GO:0005980) | 2.73939779 |
| 156 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.73245080 |
| 157 | learning (GO:0007612) | 2.72457063 |
| 158 | membrane depolarization during action potential (GO:0086010) | 2.69804162 |
| 159 | fear response (GO:0042596) | 2.69484605 |
| 160 | cardiac cell development (GO:0055006) | 2.68723764 |
| 161 | relaxation of muscle (GO:0090075) | 2.67677899 |
| 162 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.65866605 |
| 163 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.64626897 |
| 164 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.63514686 |
| 165 | cell communication involved in cardiac conduction (GO:0086065) | 2.62851922 |
| 166 | skeletal muscle adaptation (GO:0043501) | 2.62376737 |
| 167 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.60339381 |
| 168 | skeletal muscle tissue development (GO:0007519) | 2.60273699 |
| 169 | nucleus localization (GO:0051647) | 2.59910786 |
| 170 | fatty acid transmembrane transport (GO:1902001) | 2.54470654 |
| 171 | glucan catabolic process (GO:0009251) | 2.52705145 |
| 172 | striated muscle cell development (GO:0055002) | 2.52538429 |
| 173 | muscle cell cellular homeostasis (GO:0046716) | 2.50630180 |
| 174 | cardiac muscle cell action potential (GO:0086001) | 2.45680434 |
| 175 | response to epinephrine (GO:0071871) | 2.44524807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.38015721 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50484950 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77883681 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76831379 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74578215 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47079682 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47079682 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35123779 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31973661 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31668593 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30642787 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29774821 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28472065 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26162978 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26107376 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25792194 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22067334 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20381914 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.17707785 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07695618 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06809431 |
| 22 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03280353 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00550613 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00367418 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99160366 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95627784 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95105479 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86397279 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81524927 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.78837551 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75243574 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74059459 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73393740 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68783316 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67867256 |
| 36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.66618672 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66576714 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60777813 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59475904 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52051226 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51610872 |
| 42 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50907306 |
| 43 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50907306 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50592704 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47095565 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46192959 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46094891 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43991275 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41692821 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40894183 |
| 51 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39800105 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39630756 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39020844 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38030893 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35278250 |
| 56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35201881 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34882478 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32521828 |
| 59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32218592 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31674150 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31066189 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31045249 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30511346 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30282728 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30203496 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30000862 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.29703154 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29222064 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29027774 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28070403 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27996361 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27673569 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27020651 |
| 74 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26126350 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25828650 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24473481 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24364602 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22929861 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22655148 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22285152 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21829192 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20579819 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20095903 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19342391 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19234163 |
| 86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18754268 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18348238 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17994022 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17866721 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17597117 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16932732 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16139066 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15519436 |
| 94 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14244339 |
| 95 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.13498806 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13116893 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13116893 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12971799 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12668308 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11703291 |
| 101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10863831 |
| 102 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.10603943 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10563542 |
| 104 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.10229991 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09712279 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09614587 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07859765 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07576495 |
| 109 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07532260 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07393906 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06511717 |
| 112 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05402225 |
| 113 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04591095 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03942931 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02768393 |
| 116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02591589 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02460164 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02339222 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01839591 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01770446 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00910409 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00910409 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99000255 |
| 124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98376529 |
| 125 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98219913 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97546878 |
| 127 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97539747 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97405646 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96232847 |
| 130 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95924214 |
| 131 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93669583 |
| 132 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93497822 |
| 133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92987789 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91953493 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90768171 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90598636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.40569894 |
| 2 | MP0003646_muscle_fatigue | 4.09279723 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.08996202 |
| 4 | MP0004270_analgesia | 3.96385737 |
| 5 | MP0003880_abnormal_central_pattern | 3.84057684 |
| 6 | MP0000749_muscle_degeneration | 3.59262538 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.33692155 |
| 8 | MP0009745_abnormal_behavioral_response | 3.15724669 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.07183435 |
| 10 | MP0002064_seizures | 2.83766348 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.72156477 |
| 12 | MP0009046_muscle_twitch | 2.68274362 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.67767068 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.66717778 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.63335497 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55432891 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.40468322 |
| 18 | MP0001486_abnormal_startle_reflex | 2.36648825 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.32893954 |
| 20 | MP0000778_abnormal_nervous_system | 2.26475405 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.23789803 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.17039268 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.14934152 |
| 24 | MP0002272_abnormal_nervous_system | 2.13669749 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.08405599 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.03747929 |
| 27 | MP0000759_abnormal_skeletal_muscle | 2.03251029 |
| 28 | MP0005369_muscle_phenotype | 2.02445404 |
| 29 | MP0002822_catalepsy | 1.98030016 |
| 30 | MP0002269_muscular_atrophy | 1.92387416 |
| 31 | MP0002184_abnormal_innervation | 1.91375736 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.88325673 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.88005520 |
| 34 | MP0004924_abnormal_behavior | 1.86713601 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.86713601 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.85707885 |
| 37 | MP0003329_amyloid_beta_deposits | 1.83501315 |
| 38 | MP0002736_abnormal_nociception_after | 1.82231077 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.81933744 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.81731589 |
| 41 | MP0004858_abnormal_nervous_system | 1.79601719 |
| 42 | MP0001970_abnormal_pain_threshold | 1.78777703 |
| 43 | MP0008569_lethality_at_weaning | 1.77380040 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.76722202 |
| 45 | MP0000955_abnormal_spinal_cord | 1.65697684 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.64727843 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.60620542 |
| 48 | MP0004130_abnormal_muscle_cell | 1.51310527 |
| 49 | MP0004885_abnormal_endolymph | 1.49497171 |
| 50 | MP0005330_cardiomyopathy | 1.48272168 |
| 51 | MP0002108_abnormal_muscle_morphology | 1.44943870 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.44843674 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.42538001 |
| 54 | MP0003633_abnormal_nervous_system | 1.38132443 |
| 55 | MP0005187_abnormal_penis_morphology | 1.38000403 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.36241737 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.29280227 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.24523963 |
| 59 | MP0000733_abnormal_muscle_development | 1.24066637 |
| 60 | MP0002152_abnormal_brain_morphology | 1.22149288 |
| 61 | MP0001188_hyperpigmentation | 1.22052482 |
| 62 | MP0000751_myopathy | 1.21132037 |
| 63 | MP0001984_abnormal_olfaction | 1.21121345 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.21020460 |
| 65 | MP0005646_abnormal_pituitary_gland | 1.20340634 |
| 66 | MP0003787_abnormal_imprinting | 1.20206515 |
| 67 | MP0003879_abnormal_hair_cell | 1.15986617 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.15057219 |
| 69 | MP0003631_nervous_system_phenotype | 1.13581550 |
| 70 | MP0006138_congestive_heart_failure | 1.13160213 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 1.11256744 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 1.08277385 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.06722314 |
| 74 | MP0010630_abnormal_cardiac_muscle | 1.05001875 |
| 75 | MP0005385_cardiovascular_system_phenoty | 1.02809397 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.02809397 |
| 77 | MP0003122_maternal_imprinting | 1.02753111 |
| 78 | MP0008775_abnormal_heart_ventricle | 1.02289180 |
| 79 | MP0005248_abnormal_Harderian_gland | 1.00860466 |
| 80 | MP0008961_abnormal_basal_metabolism | 1.00043724 |
| 81 | MP0002971_abnormal_brown_adipose | 0.96833950 |
| 82 | MP0005535_abnormal_body_temperature | 0.96502391 |
| 83 | MP0001177_atelectasis | 0.96391183 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.95850807 |
| 85 | MP0004085_abnormal_heartbeat | 0.93784882 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.92718782 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.92484795 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.92384069 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86995325 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.86610774 |
| 91 | MP0002229_neurodegeneration | 0.86501082 |
| 92 | MP0003303_peritoneal_inflammation | 0.86179783 |
| 93 | MP0004484_altered_response_of | 0.85760929 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.85134108 |
| 95 | MP0004142_abnormal_muscle_tone | 0.84847543 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.83383476 |
| 97 | MP0004510_myositis | 0.82903081 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.82827276 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.82785487 |
| 100 | MP0000604_amyloidosis | 0.82627737 |
| 101 | MP0001905_abnormal_dopamine_level | 0.82453144 |
| 102 | MP0003634_abnormal_glial_cell | 0.81676427 |
| 103 | MP0005266_abnormal_metabolism | 0.81600321 |
| 104 | MP0002009_preneoplasia | 0.81120705 |
| 105 | MP0004233_abnormal_muscle_weight | 0.80904305 |
| 106 | MP0008874_decreased_physiological_sensi | 0.80457391 |
| 107 | MP0003632_abnormal_nervous_system | 0.79862903 |
| 108 | MP0002090_abnormal_vision | 0.79753592 |
| 109 | MP0003385_abnormal_body_wall | 0.76926226 |
| 110 | MP0004147_increased_porphyrin_level | 0.75782455 |
| 111 | MP0003861_abnormal_nervous_system | 0.75393303 |
| 112 | MP0004134_abnormal_chest_morphology | 0.74469419 |
| 113 | MP0003690_abnormal_glial_cell | 0.74255327 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.72118206 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.71276035 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.71197949 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.70262128 |
| 118 | MP0005499_abnormal_olfactory_system | 0.70262128 |
| 119 | MP0001529_abnormal_vocalization | 0.70252521 |
| 120 | MP0000747_muscle_weakness | 0.69736551 |
| 121 | MP0004742_abnormal_vestibular_system | 0.65915052 |
| 122 | MP0008872_abnormal_physiological_respon | 0.65317198 |
| 123 | MP0001661_extended_life_span | 0.64796604 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.63571217 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.63535885 |
| 126 | MP0005253_abnormal_eye_physiology | 0.63153669 |
| 127 | MP0004043_abnormal_pH_regulation | 0.62917643 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.59960412 |
| 129 | MP0000534_abnormal_ureter_morphology | 0.58905788 |
| 130 | MP0001943_abnormal_respiration | 0.57869138 |
| 131 | MP0010769_abnormal_survival | 0.57738837 |
| 132 | MP0005409_darkened_coat_color | 0.57714987 |
| 133 | MP0001963_abnormal_hearing_physiology | 0.57546076 |
| 134 | MP0010770_preweaning_lethality | 0.56447680 |
| 135 | MP0002082_postnatal_lethality | 0.56447680 |
| 136 | MP0005171_absent_coat_pigmentation | 0.55828005 |
| 137 | MP0010768_mortality/aging | 0.53134411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.43195045 |
| 2 | Nemaline bodies (HP:0003798) | 8.31914187 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.12638872 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.43100951 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 5.86884762 |
| 6 | Focal motor seizures (HP:0011153) | 5.86290178 |
| 7 | Exercise-induced myalgia (HP:0003738) | 5.62397906 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.33083279 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 5.07036566 |
| 10 | Myokymia (HP:0002411) | 5.05935223 |
| 11 | Focal seizures (HP:0007359) | 4.85201083 |
| 12 | Distal arthrogryposis (HP:0005684) | 4.67280282 |
| 13 | Visual hallucinations (HP:0002367) | 4.45672173 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 4.28701400 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.09713867 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 3.98466643 |
| 17 | Rimmed vacuoles (HP:0003805) | 3.90121799 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.88527296 |
| 19 | Difficulty running (HP:0009046) | 3.78570205 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.73746663 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.66126473 |
| 22 | Subaortic stenosis (HP:0001682) | 3.62127339 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.62127339 |
| 24 | Ankle clonus (HP:0011448) | 3.45262713 |
| 25 | Febrile seizures (HP:0002373) | 3.43854989 |
| 26 | Round ear (HP:0100830) | 3.42227866 |
| 27 | Sudden death (HP:0001699) | 3.40571632 |
| 28 | Bundle branch block (HP:0011710) | 3.40175574 |
| 29 | Papilledema (HP:0001085) | 3.38663446 |
| 30 | Absence seizures (HP:0002121) | 3.38230483 |
| 31 | Broad-based gait (HP:0002136) | 3.33485941 |
| 32 | Supranuclear gaze palsy (HP:0000605) | 3.32820673 |
| 33 | Frequent falls (HP:0002359) | 3.32732242 |
| 34 | Excessive salivation (HP:0003781) | 3.31792850 |
| 35 | Drooling (HP:0002307) | 3.31792850 |
| 36 | Atonic seizures (HP:0010819) | 3.31690281 |
| 37 | Action tremor (HP:0002345) | 3.30841513 |
| 38 | Myoglobinuria (HP:0002913) | 3.27655359 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.25240286 |
| 40 | Neck muscle weakness (HP:0000467) | 3.24279005 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.22367310 |
| 42 | Hyperventilation (HP:0002883) | 3.19723045 |
| 43 | Myopathic facies (HP:0002058) | 3.19277543 |
| 44 | Mutism (HP:0002300) | 3.18294333 |
| 45 | Generalized tonic-clonic seizures (HP:0002069) | 3.16372565 |
| 46 | Poor eye contact (HP:0000817) | 3.15486061 |
| 47 | Dialeptic seizures (HP:0011146) | 3.06921888 |
| 48 | Myotonia (HP:0002486) | 3.05709830 |
| 49 | Insidious onset (HP:0003587) | 3.04994455 |
| 50 | Termporal pattern (HP:0011008) | 3.04994455 |
| 51 | Abnormal social behavior (HP:0012433) | 2.98457266 |
| 52 | Impaired social interactions (HP:0000735) | 2.98457266 |
| 53 | Genetic anticipation (HP:0003743) | 2.96825685 |
| 54 | Truncal ataxia (HP:0002078) | 2.96361903 |
| 55 | Urinary urgency (HP:0000012) | 2.94111859 |
| 56 | Absent phalangeal crease (HP:0006109) | 2.93121475 |
| 57 | Rhabdomyolysis (HP:0003201) | 2.88837848 |
| 58 | Depression (HP:0000716) | 2.87406942 |
| 59 | Abnormality of the corticospinal tract (HP:0002492) | 2.78491734 |
| 60 | Ulnar deviation of the wrist (HP:0003049) | 2.74847224 |
| 61 | Calcaneovalgus deformity (HP:0001848) | 2.73499460 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72915577 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.72676556 |
| 64 | Absent speech (HP:0001344) | 2.67360419 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.65527890 |
| 66 | Abnormality of the lower motor neuron (HP:0002366) | 2.64351206 |
| 67 | EMG: neuropathic changes (HP:0003445) | 2.62929019 |
| 68 | Scanning speech (HP:0002168) | 2.62626187 |
| 69 | Abnormal finger flexion creases (HP:0006143) | 2.62186982 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.60883920 |
| 71 | Postural instability (HP:0002172) | 2.60692481 |
| 72 | Agitation (HP:0000713) | 2.60412694 |
| 73 | Spastic gait (HP:0002064) | 2.60068357 |
| 74 | Areflexia of lower limbs (HP:0002522) | 2.59684034 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.59293483 |
| 76 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.53405087 |
| 77 | Hepatoblastoma (HP:0002884) | 2.50159930 |
| 78 | Increased variability in muscle fiber diameter (HP:0003557) | 2.48726458 |
| 79 | Deformed tarsal bones (HP:0008119) | 2.48168620 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.47278587 |
| 81 | Dysmetria (HP:0001310) | 2.46054417 |
| 82 | Anxiety (HP:0000739) | 2.46021719 |
| 83 | Epileptiform EEG discharges (HP:0011182) | 2.42925672 |
| 84 | Amblyopia (HP:0000646) | 2.42474986 |
| 85 | Inappropriate behavior (HP:0000719) | 2.41454751 |
| 86 | Dysmetric saccades (HP:0000641) | 2.39839426 |
| 87 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38216898 |
| 88 | Inability to walk (HP:0002540) | 2.37284183 |
| 89 | Limb dystonia (HP:0002451) | 2.36804261 |
| 90 | Neoplasm of the adrenal cortex (HP:0100641) | 2.36146848 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.35420950 |
| 92 | Intention tremor (HP:0002080) | 2.33803058 |
| 93 | Lower limb muscle weakness (HP:0007340) | 2.31008161 |
| 94 | Stereotypic behavior (HP:0000733) | 2.30627007 |
| 95 | Impaired smooth pursuit (HP:0007772) | 2.30301557 |
| 96 | Megalencephaly (HP:0001355) | 2.30117606 |
| 97 | Progressive inability to walk (HP:0002505) | 2.30022151 |
| 98 | Hypsarrhythmia (HP:0002521) | 2.29764605 |
| 99 | Torticollis (HP:0000473) | 2.28979914 |
| 100 | Bradykinesia (HP:0002067) | 2.25284424 |
| 101 | Macroorchidism (HP:0000053) | 2.17433869 |
| 102 | Pheochromocytoma (HP:0002666) | 2.14574155 |
| 103 | Buphthalmos (HP:0000557) | 2.13558816 |
| 104 | Hip contracture (HP:0003273) | 2.13260721 |
| 105 | Abnormality of binocular vision (HP:0011514) | 2.12464275 |
| 106 | Diplopia (HP:0000651) | 2.12464275 |
| 107 | Impaired vibratory sensation (HP:0002495) | 2.11256116 |
| 108 | Slender build (HP:0001533) | 2.09772545 |
| 109 | Generalized muscle weakness (HP:0003324) | 2.09493670 |
| 110 | Aqueductal stenosis (HP:0002410) | 2.09374810 |
| 111 | Abnormality of salivation (HP:0100755) | 2.08733416 |
| 112 | Hemiparesis (HP:0001269) | 2.08367160 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 2.06332344 |
| 114 | Heart block (HP:0012722) | 2.06004991 |
| 115 | Scapular winging (HP:0003691) | 2.05587375 |
| 116 | Fetal akinesia sequence (HP:0001989) | 2.05117931 |
| 117 | Hypoplasia of the brainstem (HP:0002365) | 2.05010372 |
| 118 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.05010372 |
| 119 | Muscle stiffness (HP:0003552) | 2.04040151 |
| 120 | Blue irides (HP:0000635) | 2.02493579 |
| 121 | Intellectual disability, profound (HP:0002187) | 2.02466678 |
| 122 | Lipoatrophy (HP:0100578) | 2.02295667 |
| 123 | Akinesia (HP:0002304) | 2.02295631 |
| 124 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.00690449 |
| 125 | Hyperkalemia (HP:0002153) | 2.00656547 |
| 126 | Hemiplegia (HP:0002301) | 2.00353414 |
| 127 | Focal dystonia (HP:0004373) | 1.99896817 |
| 128 | Dilated cardiomyopathy (HP:0001644) | 1.99809542 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.98726936 |
| 130 | Muscular dystrophy (HP:0003560) | 1.97422306 |
| 131 | Proximal amyotrophy (HP:0007126) | 1.96600894 |
| 132 | Papillary thyroid carcinoma (HP:0002895) | 1.96071939 |
| 133 | Pachygyria (HP:0001302) | 1.95528966 |
| 134 | Increased connective tissue (HP:0009025) | 1.95232704 |
| 135 | Insomnia (HP:0100785) | 1.95190725 |
| 136 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95163644 |
| 137 | Subacute progressive viral hepatitis (HP:0006572) | 1.94967218 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.94619095 |
| 139 | Malignant hyperthermia (HP:0002047) | 1.94550311 |
| 140 | Long clavicles (HP:0000890) | 1.93011948 |
| 141 | Polyphagia (HP:0002591) | 1.92639307 |
| 142 | Ventricular tachycardia (HP:0004756) | 1.92299153 |
| 143 | Gowers sign (HP:0003391) | 1.91776227 |
| 144 | Limited hip movement (HP:0008800) | 1.91542288 |
| 145 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.91509312 |
| 146 | Pointed chin (HP:0000307) | 1.91370579 |
| 147 | Atrial fibrillation (HP:0005110) | 1.90354133 |
| 148 | Abnormality of the ischium (HP:0003174) | 1.90121012 |
| 149 | Status epilepticus (HP:0002133) | 1.88828337 |
| 150 | Ankyloglossia (HP:0010296) | 1.88213803 |
| 151 | Open mouth (HP:0000194) | 1.87190048 |
| 152 | Exotropia (HP:0000577) | 1.85529527 |
| 153 | Clonus (HP:0002169) | 1.84767507 |
| 154 | Neuroendocrine neoplasm (HP:0100634) | 1.83410507 |
| 155 | Craniofacial dystonia (HP:0012179) | 1.82370915 |
| 156 | Generalized myoclonic seizures (HP:0002123) | 1.79636498 |
| 157 | Abnormal atrioventricular conduction (HP:0005150) | 1.79134889 |
| 158 | Apathy (HP:0000741) | 1.77096556 |
| 159 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.76635931 |
| 160 | Retinal dysplasia (HP:0007973) | 1.76249844 |
| 161 | Syncope (HP:0001279) | 1.73037063 |
| 162 | Steppage gait (HP:0003376) | 1.72292662 |
| 163 | Primary atrial arrhythmia (HP:0001692) | 1.70864817 |
| 164 | Limb-girdle muscle weakness (HP:0003325) | 1.69068909 |
| 165 | Distal lower limb muscle weakness (HP:0009053) | 1.69011072 |
| 166 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.66863075 |
| 167 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.66863075 |
| 168 | Limb-girdle muscle atrophy (HP:0003797) | 1.66367362 |
| 169 | Spinal rigidity (HP:0003306) | 1.62465033 |
| 170 | Prolonged QT interval (HP:0001657) | 1.61119969 |
| 171 | Hypoplastic ischia (HP:0003175) | 1.58559269 |
| 172 | Ulnar deviation of finger (HP:0009465) | 1.57386827 |
| 173 | Abnormality of the foot musculature (HP:0001436) | 1.56421379 |
| 174 | Supraventricular tachycardia (HP:0004755) | 1.55782468 |
| 175 | Supraventricular arrhythmia (HP:0005115) | 1.53609203 |
| 176 | Left ventricular hypertrophy (HP:0001712) | 1.53440495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.36173604 |
| 2 | MARK1 | 5.41564775 |
| 3 | NTRK3 | 3.65899361 |
| 4 | MAP3K9 | 3.50678786 |
| 5 | MAP3K4 | 3.02455391 |
| 6 | EPHA4 | 3.01525687 |
| 7 | TTN | 2.97723084 |
| 8 | MINK1 | 2.69837743 |
| 9 | NTRK2 | 2.32161339 |
| 10 | MAP2K7 | 2.19644386 |
| 11 | PAK6 | 2.14679389 |
| 12 | KSR1 | 1.94155116 |
| 13 | MAP2K4 | 1.93025012 |
| 14 | DAPK2 | 1.91840048 |
| 15 | PNCK | 1.82056937 |
| 16 | PHKG2 | 1.81409184 |
| 17 | PHKG1 | 1.81409184 |
| 18 | KSR2 | 1.79296001 |
| 19 | CAMKK1 | 1.65866246 |
| 20 | PIK3CG | 1.65085630 |
| 21 | NTRK1 | 1.62924406 |
| 22 | LATS2 | 1.56824167 |
| 23 | SIK2 | 1.53783614 |
| 24 | MAPK13 | 1.44603482 |
| 25 | CDK5 | 1.42434043 |
| 26 | CASK | 1.36975507 |
| 27 | AKT3 | 1.36470067 |
| 28 | CAMK1G | 1.35725814 |
| 29 | CSNK1G2 | 1.35610541 |
| 30 | PRKD3 | 1.29110772 |
| 31 | PLK2 | 1.29019213 |
| 32 | MAP3K12 | 1.25954468 |
| 33 | LATS1 | 1.24487489 |
| 34 | MAP3K2 | 1.17747722 |
| 35 | FGFR2 | 1.12384035 |
| 36 | BMPR1B | 1.11913762 |
| 37 | RET | 1.11703516 |
| 38 | TYRO3 | 1.08459101 |
| 39 | PAK3 | 1.06594220 |
| 40 | PRKCG | 1.06299791 |
| 41 | STK38 | 1.03722637 |
| 42 | RIPK4 | 1.03141264 |
| 43 | CCNB1 | 1.02134003 |
| 44 | FES | 1.01742555 |
| 45 | MARK2 | 0.97668920 |
| 46 | STK11 | 0.96816914 |
| 47 | DAPK1 | 0.95242037 |
| 48 | UHMK1 | 0.94487023 |
| 49 | RIPK1 | 0.93996750 |
| 50 | TNIK | 0.90850266 |
| 51 | GRK5 | 0.89281628 |
| 52 | ERBB3 | 0.88153999 |
| 53 | SGK2 | 0.85323853 |
| 54 | CAMKK2 | 0.84246164 |
| 55 | SGK3 | 0.83376719 |
| 56 | SGK494 | 0.82543900 |
| 57 | SGK223 | 0.82543900 |
| 58 | CAMK2A | 0.82054670 |
| 59 | PRKCH | 0.81540880 |
| 60 | SCYL2 | 0.80531308 |
| 61 | PIK3CA | 0.80387005 |
| 62 | CSNK1A1L | 0.79950975 |
| 63 | EPHA3 | 0.79754717 |
| 64 | TAOK1 | 0.79405340 |
| 65 | LMTK2 | 0.78073989 |
| 66 | CSNK1G3 | 0.76463992 |
| 67 | CAMK1 | 0.76066668 |
| 68 | DYRK1A | 0.75871131 |
| 69 | MAP3K7 | 0.75015728 |
| 70 | SGK1 | 0.73384080 |
| 71 | FRK | 0.73189328 |
| 72 | PRKAA2 | 0.72694554 |
| 73 | PRKCZ | 0.72194403 |
| 74 | ALK | 0.71967947 |
| 75 | CDK18 | 0.71520011 |
| 76 | NEK9 | 0.71167257 |
| 77 | CDK15 | 0.69517869 |
| 78 | CDK14 | 0.69280875 |
| 79 | TRPM7 | 0.68397439 |
| 80 | MAP4K2 | 0.67439111 |
| 81 | PRPF4B | 0.66648228 |
| 82 | MUSK | 0.64713369 |
| 83 | OXSR1 | 0.64464685 |
| 84 | FER | 0.62698165 |
| 85 | CAMK2G | 0.62372428 |
| 86 | ACVR1B | 0.62081070 |
| 87 | PRKG1 | 0.58891606 |
| 88 | DYRK2 | 0.58686103 |
| 89 | CDK11A | 0.56673572 |
| 90 | PKN1 | 0.56503471 |
| 91 | STK38L | 0.56251668 |
| 92 | MAPK12 | 0.56248787 |
| 93 | PDK1 | 0.55256811 |
| 94 | DMPK | 0.54444268 |
| 95 | CSNK1G1 | 0.53077885 |
| 96 | STK39 | 0.52926949 |
| 97 | PDGFRA | 0.52825093 |
| 98 | MKNK2 | 0.52699067 |
| 99 | RAF1 | 0.52571036 |
| 100 | CAMK2D | 0.52369415 |
| 101 | FYN | 0.51979670 |
| 102 | CAMK2B | 0.51864986 |
| 103 | PRKCE | 0.51587284 |
| 104 | MAP3K6 | 0.51268794 |
| 105 | BCR | 0.51123806 |
| 106 | TIE1 | 0.50805477 |
| 107 | RPS6KA2 | 0.50701390 |
| 108 | CDK19 | 0.50534159 |
| 109 | RPS6KA3 | 0.50250661 |
| 110 | MAP2K1 | 0.50182515 |
| 111 | ROCK1 | 0.48349555 |
| 112 | PDPK1 | 0.46793310 |
| 113 | NEK1 | 0.45844311 |
| 114 | WNK3 | 0.44750541 |
| 115 | MAPK10 | 0.44210649 |
| 116 | CAMK1D | 0.43630594 |
| 117 | WNK1 | 0.42223388 |
| 118 | CAMK4 | 0.42099453 |
| 119 | PRKACB | 0.41987721 |
| 120 | PINK1 | 0.41635696 |
| 121 | LIMK1 | 0.41600987 |
| 122 | PRKACA | 0.40011990 |
| 123 | PDK4 | 0.38212577 |
| 124 | PDK3 | 0.38212577 |
| 125 | CDC42BPA | 0.37075572 |
| 126 | CSNK1D | 0.36817149 |
| 127 | RPS6KB1 | 0.36326296 |
| 128 | PRKAA1 | 0.36024854 |
| 129 | MAP3K1 | 0.35679275 |
| 130 | BRD4 | 0.35675395 |
| 131 | PTK2B | 0.34221393 |
| 132 | MAP3K10 | 0.34107314 |
| 133 | MAPK7 | 0.32161193 |
| 134 | MAPK4 | 0.31626265 |
| 135 | TRIM28 | 0.30530923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19206297 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.61733345 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46896827 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42391992 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40341167 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31812116 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28044561 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.24460544 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16227234 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.14504962 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08821938 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06377915 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.91897839 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84069313 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.79089927 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.75640723 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72995525 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69960157 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62624564 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.61690989 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57641322 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52106935 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45403502 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44661218 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.44641196 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.43310103 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38845835 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.38802446 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35731012 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35404734 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.35181323 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34034754 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.33590939 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32736766 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.28732010 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23149886 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20427625 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19043235 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17376401 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15862084 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11660093 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.07693110 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07430765 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05860474 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96376243 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96132354 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94284017 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93206177 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89527306 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85818246 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85028677 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84581944 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 0.83799208 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83635729 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82946101 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80748994 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80122902 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78490328 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78466819 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77082228 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76724612 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74925266 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.74239187 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73740334 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73445056 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.72023422 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71727149 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71357287 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70722215 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70721496 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70392282 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.70108633 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68457960 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67426721 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65899270 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65489628 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64690029 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64419574 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63259972 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62438391 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62157113 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61898319 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61459407 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60632194 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60259883 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59776653 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59766223 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59260056 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59259501 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59159459 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59033984 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59024630 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58067037 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57635850 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56776382 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55567769 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55463093 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55041865 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54487706 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50926942 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49300382 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.49101555 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.48828630 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47735519 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.47392885 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47099394 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45319333 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45221343 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45184538 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45146617 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44984601 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.44887342 |
| 113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44522812 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44179678 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.43939482 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43462230 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.43355236 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42878473 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42427113 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42011780 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40605947 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40493541 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38081355 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.36168012 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32520718 |

